Genomic testing for patient care, clinical trials and translational research

Genomics and Pathology Services (GPS) at Washington University in St. Louis provides physicians with clinically validated next-generation sequencing for cancer, somatic overgrowth and a variety of constitutional diseases. Due to our extensive technological capabilities we also offer customized tests for clinical trials and clinical research.

CLINICAL TESTS REQUISITIONS

Jun 21, 2016

PRODUCT UPDATE: New genes added to GPS’ SOMA testing

To better serve our customers and their patients, we have made updates to our SOMA genomic testing, which provides next-generation sequencing …

Jun 21, 2016

PUBLICATION: Utility of Clinical High-Depth Next Generation Sequencing for Somatic Variant Detection in the PIK3CA Related Overgrowth Spectrum

GPS faculty recently published a paper in Clinical Genetics that describes how NGS is being used in PIK3CA related overgrowth syndromes. …

Jun 7, 2016

EVENT: David W. Smith Workshop on Malformations & Morphogenesis – Sept. 9-14 in Lake Arrowhead, CA

WashU physician, and GPS collaborator, Dr. Kathy Grange has been selected for a platform presentation at this prestigious clinical genetics …

More News

Whether inherited or not, cancer is a genetic disease and decoding its DNA can help better diagnose, treat and manage it. Doctors can now take advantage of cutting-edge technologies, such as next-generation sequencing, to make personalized medicine a reality for many cancer patients.